Irritable Bowel Syndrome Treatment Market Size is Projected to Reach USD 7.31 Billion by 2033, Growing at a CAGR of 8.6%: Straits Research
The global irritable bowel syndrome treatment market size was valued at USD 3.48 billion in 2024 and is projected to reach ...
Physician's Weekly2d
Peptide-1 Agonist Relieves IBS Pain but Raises Side Effects
The following is a summary of “Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a ...
Onlymyhealth16d
Be Wary Of THESE 8 Hidden Signs of Bile Acid Malabsorption That Often Mimic IBS
It is normal for two illnesses symptoms to overlap but if both have been correctly diagnosed choosing a course of therapy is ...
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
About Immuron Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and ...
Healthline23d
Your guide to understanding Irritable Bowel Syndrome With Diarrhea (IBS-D)
IBS-D is a subtype of IBS characterized by diarrhea. The triggers can vary among different people, but knowing finding out your potential triggers can help improve your daily life. Lifestyle ...
Medscape9d
Food Antibody Test Guides Diet in Irritable Bowel Syndrome
Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...
Medical News Today17d
What to know about IBS chest pain
Probiotics, which refer to living microorganisms, are another possible treatment for IBS. They are similar to the microorganisms typically present in the digestive tract and may help treat IBS ...
The #1 Spice to Help Reduce Bloating, According to Dietitians
If you’re dealing with occasional bloating, this spice may help you feel better—and it comes with other digestive perks, too.
Irish Medical Times10d
You might be interested in…Irritable Bowel syndrome
Dr Ray O’Connor takes a look at some of the most recent clinical studies on irritable bowel syndrome (IBS) ...
Morningstar10d
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
Immuron will launch ProIBS® for the treatment of symptoms related to IBS in the retail pharmacy sales channel. Immuron has been a leader in digestive health in Australia for many years.